Literature DB >> 21092063

Immune surveillance of the normal human CNS takes place in dependence of the locoregional blood-brain barrier configuration and is mainly performed by CD3(+)/CD8(+) lymphocytes.

Christian Loeffler1, Klaus Dietz, Ariane Schleich, Holger Schlaszus, Manuel Stoll, Richard Meyermann, Michel Mittelbronn.   

Abstract

Despite the blood-brain barrier (BBB) the human CNS is continuously screened by blood-derived immunological cells. In certain brain areas the local BBB configuration grants passage of large molecules, whereas others are better shielded. We investigated whether these regional BBB compositions are paralleled by differences in the degree of cellular immunosurveillance by investigating tissue from 23 normal human brains for several CD markers, FoxP3, granzyme B, and perforin. Our results provide evidence that immunosurveillance is associated with locoregional BBB configuration and is mainly performed by CD3(+)/CD8(+)/granzyme B(-)/perforin(-) lymphocytes.
© 2010 Japanese Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21092063     DOI: 10.1111/j.1440-1789.2010.01167.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  18 in total

1.  Dynamic Contrast-Enhanced MRI Reveals Unique Blood-Brain Barrier Permeability Characteristics in the Hippocampus in the Normal Brain.

Authors:  J Ivanidze; M Mackay; A Hoang; J M Chi; K Cheng; C Aranow; B Volpe; B Diamond; P C Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-07       Impact factor: 3.825

2.  Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.

Authors:  Erin E Longbrake; Claudia Cantoni; Salim Chahin; Francesca Cignarella; Anne H Cross; Laura Piccio
Journal:  Mult Scler       Date:  2017-05-08       Impact factor: 6.312

3.  Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury.

Authors:  Rodney M Ritzel; Joshua Crapser; Anita R Patel; Rajkumer Verma; Jeremy M Grenier; Anjali Chauhan; Evan R Jellison; Louise D McCullough
Journal:  J Immunol       Date:  2016-03-09       Impact factor: 5.422

Review 4.  The anatomy and immunology of vasculature in the central nervous system.

Authors:  Panagiotis Mastorakos; Dorian McGavern
Journal:  Sci Immunol       Date:  2019-07-12

5.  Characterization of the inflammatory response to solid cancer metastases in the human brain.

Authors:  Anna Sophie Berghoff; Hans Lassmann; Matthias Preusser; Romana Höftberger
Journal:  Clin Exp Metastasis       Date:  2012-07-01       Impact factor: 5.150

Review 6.  T-cell surveillance of the human brain in health and multiple sclerosis.

Authors:  Joost Smolders; Marvin M van Luijn; Cheng-Chih Hsiao; Jörg Hamann
Journal:  Semin Immunopathol       Date:  2022-04-01       Impact factor: 9.623

7.  Co-culture model consisting of human brain microvascular endothelial and peripheral blood mononuclear cells.

Authors:  Marianne Strazza; Monique E Maubert; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  J Neurosci Methods       Date:  2016-05-20       Impact factor: 2.390

8.  Molecular Signals Involved in Human B Cell Migration into the Retina: In Vitro Investigation of ICAM-1, VCAM-1, and CXCL13.

Authors:  Arpita S Bharadwaj; Andrew J Stempel; Antoinette Olivas; Samone E Franzese; Liam M Ashander; Yuefang Ma; Shervi Lie; Binoy Appukuttan; Justine R Smith
Journal:  Ocul Immunol Inflamm       Date:  2016-07-05       Impact factor: 3.070

9.  Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma.

Authors:  Ranjith Babu; D Cory Adamson
Journal:  Core Evid       Date:  2012-09-14

Review 10.  New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  Anna Bellizzi; Elena Anzivino; Donatella Maria Rodio; Anna Teresa Palamara; Lucia Nencioni; Valeria Pietropaolo
Journal:  Clin Dev Immunol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.